These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28104340)

  • 1. Why new antibiotics are not obviously useful now.
    Dubourg G; Abat C; Raoult D
    Int J Antimicrob Agents; 2017 May; 49(5):549-553. PubMed ID: 28104340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical consequences of antimicrobial resistance.
    Rice LB
    Curr Opin Microbiol; 2009 Oct; 12(5):476-81. PubMed ID: 19716760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The GISA call to action for the appropriate use of antimicrobials and the control of antimicrobial resistance in Italy.
    Menichetti F; Falcone M; Lopalco P; Tascini C; Pan A; Busani L; Viaggi B; Rossolini GM; Arena F; Novelli A; De Rosa F; Iannazzo S; Cohen J;
    Int J Antimicrob Agents; 2018 Aug; 52(2):127-134. PubMed ID: 29802887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibiotic stewardship--state of the art].
    Carmeli Y
    Dtsch Med Wochenschr; 2014 Nov; 139 Suppl 3():S99-S100. PubMed ID: 25429544
    [No Abstract]   [Full Text] [Related]  

  • 5. Spontaneous bacterial peritonitis due to multidrug resistant bacteria: are the current guidelines outdated?
    Fiore M
    Eur J Gastroenterol Hepatol; 2016 Jun; 28(6):731. PubMed ID: 27111388
    [No Abstract]   [Full Text] [Related]  

  • 6. A systematic review on the excess health risk of antibiotic-resistant bloodstream infections for six key pathogens in Europe.
    Hassoun-Kheir N; Guedes M; Ngo Nsoga MT; Argante L; Arieti F; Gladstone BP; Kingston R; Naylor NR; Pezzani MD; Pouwels KB; Robotham JV; Rodríguez-Baño J; Tacconelli E; Vella V; Harbarth S; de Kraker MEA;
    Clin Microbiol Infect; 2024 Mar; 30 Suppl 1():S14-S25. PubMed ID: 37802750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evolution of susceptibility to antibiotics of Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumanii, in a University Hospital Center of Beirut between 2005 and 2009].
    Hamouche E; Sarkis DK
    Pathol Biol (Paris); 2012 Jun; 60(3):e15-20. PubMed ID: 21719212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excess resource use and cost of drug-resistant infections for six key pathogens in Europe: a systematic review and Bayesian meta-analysis.
    Kingston R; Vella V; Pouwels KB; Schmidt JE; Abdelatif El-Abasiri RA; Reyna-Villasmil E; Hassoun-Kheir N; Harbarth S; Rodríguez-Baño J; Tacconelli E; Arieti F; Gladstone BP; de Kraker MEA; Naylor NR; Robotham JV;
    Clin Microbiol Infect; 2024 Mar; 30 Suppl 1():S26-S36. PubMed ID: 38128781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of multidrug-resistant bacteria at a tertiary-care teaching hospital in Mexico: special focus on Acinetobacter baumannii.
    Garza-González E; Llaca-Díaz JM; Bosques-Padilla FJ; González GM
    Chemotherapy; 2010; 56(4):275-9. PubMed ID: 20693798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic consumption and resistance: results of the SPIN-UTI project of the GISIO-SItI.
    Agodi A; Auxilia F; Barchitta M; Brusaferro S; D'Errico MM; Montagna MT; Pasquarella C; Tardivo S; Mura I;
    Epidemiol Prev; 2015; 39(4 Suppl 1):94-8. PubMed ID: 26499423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic resistance in Swiss nursing homes: analysis of National Surveillance Data over an 11-year period between 2007 and 2017.
    Kohler P; Fulchini R; Albrich WC; Egli A; Balmelli C; Harbarth S; Héquet D; Kahlert CR; Kuster SP; Petignat C; Schlegel M; Kronenberg A
    Antimicrob Resist Infect Control; 2018; 7():88. PubMed ID: 30038781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nonlinear time-series analysis approach to identify thresholds in associations between population antibiotic use and rates of resistance.
    López-Lozano JM; Lawes T; Nebot C; Beyaert A; Bertrand X; Hocquet D; Aldeyab M; Scott M; Conlon-Bingham G; Farren D; Kardos G; Fésűs A; Rodríguez-Baño J; Retamar P; Gonzalo-Jiménez N; Gould IM;
    Nat Microbiol; 2019 Jul; 4(7):1160-1172. PubMed ID: 30962570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of antimicrobial consumption on gram-negative bacteria in inpatients receiving antimicrobial resistance therapy from 2008-2013 at a tertiary hospital in Shanghai, China.
    Guo W; He Q; Wang Z; Wei M; Yang Z; Du Y; Wu C; He J
    Am J Infect Control; 2015 Apr; 43(4):358-64. PubMed ID: 25838134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The Age of Multidrug Resistance: Ten Year Incidence in a Neonatal Intensive Care Unit].
    Sanches B; Guerreiro R; Diogo J; Cabral M; Gomes A
    Acta Med Port; 2020 Mar; 33(3):183-190. PubMed ID: 32130097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Trend in the susceptibility of the most frequent bacterial pathogens isolated at Hospital General La Mancha Centro over 2010-2012 period].
    Asencio MÁ; Huertas M; Carranza R; Franco M; Castellanos J; Barberá JR; Conde Mdel C; Tenías JM
    Rev Esp Quimioter; 2014 Dec; 27(4):261-8. PubMed ID: 25536430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Do we really need new antibiotics?].
    Putensen C
    Dtsch Med Wochenschr; 2014 Nov; 139 Suppl 3():S83-4. PubMed ID: 25429536
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug resistance patterns of bacteria isolated from patients with nosocomial pneumonia at Tehran hospitals during 2009-2011.
    Haeili M; Ghodousi A; Nomanpour B; Omrani M; Feizabadi MM
    J Infect Dev Ctries; 2013 Apr; 7(4):312-7. PubMed ID: 23592640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug-Resistant Gram-Negative Bacterial Infections in the Hospital Setting: Overview, Implications for Clinical Practice, and Emerging Treatment Options.
    Cerceo E; Deitelzweig SB; Sherman BM; Amin AN
    Microb Drug Resist; 2016 Jul; 22(5):412-31. PubMed ID: 26866778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Collateral damage of cephalosporins and quinolones and possibilities for control].
    Saner FH; Canbay A; Gerken G; Broelsch CE
    Med Klin (Munich); 2009 Feb; 104(2):114-8. PubMed ID: 19242662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in solid-organ transplant recipients.
    Bodro M; Sabé N; Tubau F; Lladó L; Baliellas C; Roca J; Cruzado JM; Carratalà J
    Transplantation; 2013 Nov; 96(9):843-9. PubMed ID: 23883973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.